PNPLA3 and metabolic dysfunction-associated steatotic liver disease: About 9,229 genetic variants of PNPLA3 showed that homozygous carriers of the I148M variant protein of PNPLA3 had twice the greater hepatic fat content than non-carriers, and I148M was more common in the group who were at the highest risk of NAFLD.